Disopyramide 1 mg/mL Oral Syrup is a concentrated liquid formulation designed for oral administration. It contains active ingredients and sweeteners, providing a palatable and easy-to-administer dosage form. This formulation is particularly beneficial for pediatric patients or individuals who have difficulty swallowing tablets or capsules.
This oral syrup is used in the treatment of arrhythmias, specifically ventricular arrhythmias, helping to maintain a regular heart rhythm and manage symptoms associated with these conditions.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Disopyramide 1 mg/mL Oral Syrup is a custom-compounded liquid formulation designed to provide a palatable and easily administered dosage form of disopyramide, an antiarrhythmic medication. This formulation is particularly beneficial for pediatric patients or individuals who have difficulty swallowing tablets or capsules, ensuring they receive the accurate dosage required for their treatment.
Disopyramide is used to treat certain types of serious irregular heartbeat, such as ventricular tachycardia and other life-threatening arrhythmias. It works by stabilizing the electrical activity of the heart, helping to maintain a normal and regular heartbeat. By preventing abnormal heart rhythms, disopyramide reduces symptoms like palpitations, dizziness, and fainting, and decreases the risk of complications such as stroke or cardiac arrest.
The oral syrup formulation allows for precise dosing adjustments, which is essential for individualized patient care. This is especially important in populations with variable dosage requirements, such as children or patients with renal impairment. The syrup is formulated with sweeteners to improve taste, thereby enhancing patient compliance with the treatment regimen.
Patients should take Disopyramide Oral Syrup exactly as prescribed by their healthcare provider. It is important to measure each dose carefully using a proper measuring device to ensure accuracy. Do not use household spoons, as they may not provide the correct dosage. The medication should be taken at evenly spaced intervals to maintain consistent levels in the bloodstream.
Potential side effects may include dry mouth, blurred vision, constipation, urinary retention, and low blood sugar levels. Patients should be monitored for signs of heart failure, hypotension, or worsening arrhythmias. It is crucial to report any adverse effects or unusual symptoms to a healthcare provider promptly.
For prescribers, when considering Disopyramide Oral Syrup, it is important to assess the patient's overall health status, including kidney and liver function, as dosage adjustments may be necessary. Continuous monitoring through electrocardiograms (ECGs) and plasma disopyramide levels can help in optimizing therapeutic outcomes and minimizing risks. This formulation provides flexibility in dosing, which can be advantageous in managing complex cases.
If you have any questions, reach out to us.
Disopyramide is an antiarrhythmic medication used primarily to treat certain types of serious irregular heartbeat conditions, such as ventricular tachycardia. By restoring normal heart rhythm and maintaining a regular, steady heartbeat, disopyramide helps to prevent complications associated with arrhythmias, such as stroke or heart failure.
When considering the use of Disopyramide 1 mg/mL Oral Syrup, it is crucial to be aware of potential drug interactions that may affect the efficacy and safety of the treatment. Disopyramide is metabolized by the liver enzyme CYP3A4, and its plasma concentration can be affected by other medications that inhibit or induce this enzyme. For instance, concurrent use of CYP3A4 inhibitors such as ketoconazole, erythromycin, or ritonavir can increase disopyramide levels, potentially leading to toxicity. Symptoms of disopyramide toxicity may include severe hypotension, cardiac arrest, or anticholinergic effects such as urinary retention and dry mouth.
Conversely, CYP3A4 inducers like rifampin, phenytoin, or St. John's Wort may decrease the plasma concentration of disopyramide, reducing its therapeutic efficacy and increasing the risk of arrhythmias. It is important for prescribers to monitor patients closely and adjust the disopyramide dosage as necessary when these medications are introduced or discontinued.
Additionally, disopyramide has anticholinergic properties, which can be exacerbated by other anticholinergic drugs such as antihistamines, tricyclic antidepressants, or certain antipsychotics. This can lead to increased side effects such as dry mouth, constipation, blurred vision, or urinary retention. Patients should be advised to report any new or worsening symptoms to their healthcare provider promptly.
Disopyramide may also interact with other medications that affect cardiac conduction or contractility. For example, concurrent use with other antiarrhythmic agents, beta-blockers, or calcium channel blockers can increase the risk of additive effects on cardiac conduction, potentially leading to bradycardia or heart block. It is essential for healthcare providers to evaluate the risk-benefit ratio of such combinations and to monitor cardiac function closely.
Furthermore, disopyramide can affect blood glucose levels, and caution is advised when it is used in patients taking insulin or oral hypoglycemic agents. Patients with diabetes should monitor their blood glucose levels regularly and report any significant changes to their healthcare provider.
Patients and prescribers should also be aware of the potential for disopyramide to interact with medications that alter electrolyte balance, such as diuretics. Hypokalemia or hyperkalemia can exacerbate the proarrhythmic effects of disopyramide, necessitating careful monitoring of electrolyte levels and appropriate management.
Patients and prescribers should maintain open communication and monitor for any adverse effects or changes in therapeutic response. If you have any questions or require further information, please reach out to us at Bayview Pharmacy.
Disopyramide 1 mg/mL Oral Syrup is a specialized compounded formulation designed to deliver the antiarrhythmic medication disopyramide in a liquid form. This formulation is particularly beneficial for patients who have difficulty swallowing tablets or capsules, such as pediatric patients or those with certain medical conditions that impair swallowing. The syrup is concentrated, allowing for precise dosing and ease of administration, which is crucial for managing conditions that require strict adherence to dosing schedules.
Disopyramide works by affecting the electrical activity of the heart, specifically targeting the sodium channels in cardiac cells. It belongs to a class of medications known as Class IA antiarrhythmics. By blocking these sodium channels, disopyramide slows down the conduction of electrical impulses through the heart, which helps to stabilize the heart rhythm. This action is particularly useful in treating arrhythmias, such as ventricular tachycardia and atrial fibrillation, where the heart beats irregularly or too quickly. By restoring a normal heart rhythm, disopyramide helps to improve cardiac efficiency and reduce symptoms associated with arrhythmias, such as palpitations, dizziness, and shortness of breath.
The oral syrup formulation of disopyramide is compounded with sweeteners to enhance its palatability, making it more acceptable for patients who may be sensitive to the taste of medications. This is especially important in pediatric populations, where taste can significantly impact adherence to medication regimens. The liquid form also allows for flexible dosing, which can be adjusted based on the patient's specific needs and response to treatment. This flexibility is crucial in managing arrhythmias, as the therapeutic range for disopyramide can vary between individuals.
For prescribers, the use of disopyramide in an oral syrup form provides an alternative to traditional tablet or capsule formulations, offering a solution for patients who require a liquid dosage form. It is important to monitor patients closely for any potential side effects, such as dry mouth, urinary retention, or changes in vision, which are associated with disopyramide's anticholinergic properties. Regular follow-up and possibly adjusting the dose may be necessary to ensure optimal therapeutic outcomes while minimizing adverse effects.
If you have any questions about Disopyramide 1 mg/mL Oral Syrup or its use in treating arrhythmias, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to ensure the best possible care for your patients.
Disopyramide 1 mg/mL Oral Syrup is used to treat certain types of serious irregular heartbeat, such as ventricular tachycardia. It helps to restore normal heart rhythm and maintain a regular, steady heartbeat.
This formulation is particularly beneficial for pediatric patients or individuals who have difficulty swallowing tablets or capsules, providing an easier method of administration.
Disopyramide Oral Syrup should be taken by mouth, usually as directed by your healthcare provider. It is important to follow the prescribed dosage and schedule to ensure effectiveness and safety.
Store Disopyramide Oral Syrup at room temperature, away from light and moisture. Do not store it in the bathroom, and keep it out of reach of children and pets.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Disopyramide Oral Syrup can be taken with or without food. However, it is best to follow your healthcare provider's instructions regarding food intake.
Common side effects may include dry mouth, constipation, blurred vision, and dizziness. If you experience severe side effects such as fainting, severe dizziness, or signs of infection, seek medical attention immediately.
Disopyramide Oral Syrup is often used in pediatric populations, but the safety and dosage should be determined by a healthcare provider based on the child's specific condition and needs.
Disopyramide may cause dizziness or blurred vision. Avoid driving, using machinery, or performing any activity that requires alertness until you are sure you can perform such activities safely.
In case of overdose, seek immediate medical attention or contact a poison control center. Symptoms of overdose may include severe dizziness, fainting, or irregular heartbeat.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally